Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • grepasky
    Junior Member
    • Jan 2017
    • 3

    Applications are now invited for the FIMM-EMBL International PhD program

    In collaboration with the Nordic EMBL Partnership in Molecular Medicine and the Helsinki Institute for Information Technology, FIMM announces the opening of the 2018 call for applications for Doctoral Students in Molecular Medicine, Bioinformatics, and Data Science as part of the FIMM-EMBL International PhD recruitment and training program (https://www.fimm.fi/en/training/doct...ernational-phd). In this program, outstanding doctoral students are recruited to the institute-level rotation program where they will work with two to three different research groups during a six to nine month period prior to matching to a research group in which they remain for their doctoral studies. The program provides an exciting opportunity to explore different research areas and working environments as well as to learn a variety of science and technologies, making connections within and beyond the institutes.

    We hope that you will share these call announcements with your international and national networks. The detailed call announcement can be found on the FIMM Open Positions page (https://www.fimm.fi/en/open-positions). The deadline for applications is 8 February 2018, and application instructions are available within the announcement.

    Questions are welcome to FIMM’s Doctoral Training Coordinator, William Hennah ([email protected]).

Latest Articles

Collapse

  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM
  • SEQadmin2
    Cancer Drug Resistance: The Lingering Barrier to Rising Survival
    by SEQadmin2



    Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

    There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
    07-08-2026, 05:17 AM
  • GATTACAT
    Reply to Nine Things a Sample Prep Scientist Thinks About Before Sequencing
    by GATTACAT
    Love this - good data definitely starts from good input, and poor input can only give relatively poor data. I particularly like the mention of Nanodrop/absorbance based methods for quantification. It's such a toss up if you'll get an accurate reading or what amounts to a randomly generated number, and a lot of library/sequencing related issues can be traced back to poor quant.
    07-01-2026, 11:43 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 07-13-2026, 10:26 AM
0 responses
22 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-09-2026, 10:04 AM
0 responses
32 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-08-2026, 10:08 AM
0 responses
20 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-07-2026, 11:05 AM
0 responses
34 views
0 reactions
Last Post SEQadmin2  
Working...